UCB Group said it is investing in new manufacturing capacity for radiation-cure materials with production expansions in Spain, Belgium, the United States and China.

UCB Group, Drogenbos, Belgium, said it is investing in new manufacturing capacity for radiation-cure materials with production expansions in Spain, Belgium, the United States and China. The expansions will boost monomer capacity by 25,000 tons per year, with new capacity scheduled to begin production this year in the United States and Spain, and in 2001 in China and Belgium. The company also plans to boost production capacity for oligomers at plants in Belgium and North Augusta, GA.